Prevalence of trichomoniasis among pregnant women attending ante-natal clinic in Bauchi state, Nigeria

Sunday Danladi Inusa; Chukwunonso Uche Udechukwu; Sam Mao Panda; Farida Gumau Garba

doi:10.30574/gscbps.2018.2.3.0010

Authors

Sunday Danladi Inusa Department of Biological Sciences, Abubakar Tafawa Balewa University, P.M.B. 0248, Bauchi, Bauchi State, Nigeria.
Chukwunonso Uche Udechukwu Department of Biological Sciences, Abubakar Tafawa Balewa University, P.M.B. 0248, Bauchi, Bauchi State, Nigeria.
Sam Mao Panda Department of Biological Sciences, Abubakar Tafawa Balewa University, P.M.B. 0248, Bauchi, Bauchi State, Nigeria.
Farida Gumau Garba Department of Biological Sciences, Abubakar Tafawa Balewa University, P.M.B. 0248, Bauchi, Bauchi State, Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2018.2.3.0010

Keywords:

Trichomonas vaginalis, Trichomoniasis, High vaginal swab, Microscopy, Bauchi

Abstract

Trichomoniasis is one of the most common sexually transmitted infections. The infection may lead to some complication in pregnancy; it has been related with premature labor and low birth weight. High vaginal swabs (HVS) and urine samples, 100 each, were collected from consenting pregnant women and examined for the presence of T. vaginalis under the microscope using direct wet mount microscopy within 2 hours of collection. Out of 200 samples examined, 46 (23.0%) were found to be infected with T. vaginalis; 17(17%) in General Hospital Bayara and 29 (29%) in Specialist Hospital Bauchi. There is no significant difference in the hospitals used (P>0.05). Women in the age group 25-35 years had the highest prevalence rate of 27.4%, while the lowest rate of 7.1% was observed in women at the age group 36-45, but difference was statistically insignificant(P>0.05) among the age groups. Women in their second trimester had the highest prevalence rate of 24.5% while the lowest prevalence rate of 21% was noted among those in their third trimester. Comparing HVS and urine microscopy showed that HVS had a prevalence of 31% while urine had 15%; the difference in their detection was statistically insignificant (P>0.05). In relation to number of birth, women at first birth had the highest prevalence (34.4%) while the lowest prevalence (17.5%) was observed in women at second birth. These findings are useful for ante-natal care and protection against STDs. The need for improved personal hygiene and other intervention programmes among these vulnerable groups of women is advocated.

Metrics

Metrics Loading ...

References

Hirt RP and Sherrard J. (2015). Trichomonas vaginalis origins, molecular pathobiology and clinical considerations. Current Opinion on Infectious Diseases 28(1), 72–79.

Kissinger P and Adamski A. (2013). Trichomoniasis and HIV interactions: a review. Sexually Transmitted Infections, 89(6), 426–433.

Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ and Ferris MJ. (2013). Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. Journal of Infectious Diseases, 207(12), 1922–1931.

Soper D. (2004). Trichomoniasis: under control or undercontrolled?. American Journal of Obstetrics and Gynecology; 190(1), 281-90.

Pugh M. (1982). Vaginal discharge in primary care gynecology post graduate doctor, Africa, 338-343.

Sorvillo F, Swith L, Kernat P and Ash L. (2001). T. vaginalis, HIV and African-Americans. Emerging infectious diseases, 7(6), 927-932.

Bowden FJ and Garnett GP. (2000). Trichomonas vaginalis epidemiology: parameterizing and analyzing a model of treatment interventions. Sexually transmitted infections, 76(4), 248-256.

WHO (2016). Sexually transmitted infections (STIs). Fact sheet, updated August 2016. http://www.who.int/mediacentre/factsheets/fs110/en/

Centers for Disease Control and Prevention (2006). Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 55(11), 1-94.

Obiajuru IOC and Ogbulie JN. (2005). Comparative study of the prevalence of sexually transmitted diseases between pregnant women and non-pregnant women in Imo state, Nigeria. Global Journal of Pure and Applied Sciences, 3(11), 339-342.

Jombo GTA, Egah DZ, Banwate EB and Opajobi SO. (2006). High vaginal and endocervical swabs: A bacteriological study of 8,433 samples in Jos, Nigeria. Journal of Medical Laboratory Science, 15(2), 41-46.

Adeoye GO and Akande AH. (2007). Epidemiology of Trichomonasvaginalis among women in Lagos Metropolis, Nigeria. Pakistan Journal of Biological Sciences, 10(13), 2198-2201.

Uneke CJ, Cletus, DC, Ugwuoru EA and Mirian A. (2006). Trichomonas vaginalis infection among pregnant women in South-Eastern Nigeria: Public health significance. The Internet Journal of Gynaecology and Obstetrics, 6(1), 1528-1540.

Vieira Pde B, Giordani RB, Macedo AJ and Tasca T. (2015). Natural and synthetic compound anti-Trichomonas vaginalis: An Update Review. Parasitological Research, 114(4), 1249–1261.

Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, Umbers AJ, Ndrewei N, Siba P, Li WaiSuen CS and Vallely A. (2015). Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sexually Transmitted Infection, 91(3), 194–200.

Klouman E, Masenga EJ and Klepp AB. (1997). HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 14, 163-168

Mirza NB, Nzanze H, Li DC and Piot P. (1983). Microbiology of vaginal discharge in Nairobi, Kenya. British Journal of Venereal Diseases, 59, 186-188.

World Health Organization (WHO). (2004). Integrating care for reproductive health, sexually transmitted and other reproductive tract infections; a guide to essential practice, morbidity mortality. Weekly Recommendation Report, 51(RR-2), 1-118.

Okpara K, Udoidung N, Ating I, Bassey E, Okon O and Nwabueze A. (2009). Risk factors for vaginal trichomoniasis among women in Uyo, Nigeria. The Internet Journal of Health. 2(9), 1528-8315.

Depuydt CE, Leuridan E, Van Damme P, Bogers J, Vereecken AJ and Donders GG. (2010). Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders. Gynecology Obstetrics Investigation, 70(4), 273–280.

Njoku AJ, Obiajuru OG, Njoku CJ, Nwankwo EA, Uweazouke JC and Anosike JC. (2001). The prevalence of T. vaginalis among students of higher institution in Imo states. Nigerian Journal of Parasitology, 21, 83-94.

Usanga L, Abia-Bassey P, Inyang-etoh S, Udoh F, Ani E andArchibong. (2009). Trichomonas vaginalis infection among pregnant women in Calabar, Cross River State, Nigeria. The Internet Journal of Gynecology and Obstetrics, 2(14).

Mbizro EM, Msuya and Stray P. (2001). Determinants of reproductive tract infection among asymptomatic women, Zimbabwe. Central African Journals, 47, 57-64.

Agboola A. (2006).Vaginal discharge: obstetrics and gynecology for medical students. 2nd ed. Heinemann Educational Books. (Nigeria), 548.

Amadi ANC and Nwagbo AK. (2013). T. vaginalis infection among Women in Ikwuano, Abia State Nigeria. Journal of Applied Sciences and Environmental Management, 17(3), 389-393.

Ojurongbe O, Taiwo, BO, Dina BO, Sina-Agbaje OR, Bolaji OS and Adeyeba AO. (2010). Prevalence of Trichomonas vaginalis infection among pregnant women in Abeokuta, Nigeria. Sierra Leone Journal of Biomedical Research, 2(2), 82-86.

Silver BJ, Guy RJ, Kaldor JM, Jamil MS and Rumbold AR. (2014).Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sexually Transmitted Disease, 41(6), 369–376.

Adamski A, Clark RA, Mena L, Henderson H, Levison J, Schmidt N, Gebrekristos HT, Martin DH and Kissinger P. (2014). The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women. Clinical Infectious Disease, 59(6), 883–887.

Reed-Guy, L and Jewel T. (2016). Trichomoniasis. Medically reviewed by Judith Marcin. http://www.healthline.com/health/trichomonas-infection#overview1